| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/27/2000 | WO1999061623A3 Genetic method for producing riboflavin |
| 01/27/2000 | WO1999061599A3 Recombinant narbonolide polyketide synthase |
| 01/27/2000 | WO1999061595A3 Adeno-associated viral vector-mediated expression of factor viii activity |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/27/2000 | WO1999059624A3 Composition for inducing a tumor-specific immune response, method for the production and utilization of said composition in the treatment of neoplasia |
| 01/27/2000 | WO1999058682A3 Compounds from moraxella catarrhalis |
| 01/27/2000 | WO1999058655A3 Phage display selection system for folded proteins |
| 01/27/2000 | WO1999058564B1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 01/27/2000 | WO1999057278A3 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
| 01/27/2000 | WO1999055840A8 A transcription factor and method for regulation of seed development, quality and stress-tolerance |
| 01/27/2000 | WO1999054510A3 Quantitative analysis of gene expression |
| 01/27/2000 | WO1999054465A9 Gene encoding syntaxin interacting protein |
| 01/27/2000 | WO1999053085A3 Selective regulation of adenovirus production |
| 01/27/2000 | WO1999052925A9 Programmed cell death and caspase-12 |
| 01/27/2000 | WO1999047686A3 Human mekk proteins, corresponding nucleic acid molecules, and uses therefor |
| 01/27/2000 | WO1999047536A3 Method for conducting the synthesis of nucleic acid molecules |
| 01/27/2000 | WO1999039735A9 Live vaccine for human immunodeficiency virus |
| 01/27/2000 | WO1999023227A9 Hyaluronan synthase gene and uses thereof |
| 01/27/2000 | WO1998046257A8 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 01/27/2000 | DE19856301C1 Regulatory protein pKe83 from human epidermal keratinocytes and related nucleic acid, vectors and antibodies |
| 01/27/2000 | DE19833476A1 New genetically modified, adherently growing CD34-negative stem cells for transfer of gene therapy constructs for treatment of immunodeficiency and metabolic disorders |
| 01/27/2000 | DE19831637A1 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
| 01/27/2000 | CA2720311A1 A method of producing cells with a desired property by recursive sequence recombination |
| 01/27/2000 | CA2613125A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2337843A1 Process for preparing clavam derivatives by using polypeptides having beta-lactam synthetase activity |
| 01/27/2000 | CA2337835A1 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | CA2337635A1 Method of making proteins in transformed yeast cells |
| 01/27/2000 | CA2337511A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 01/27/2000 | CA2337362A1 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | CA2337231A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | CA2337230A1 Stereoselective reductive amination of ketones |
| 01/27/2000 | CA2337096A1 Constitutive disease resistance gene (cdr1), and methods of use thereof |
| 01/27/2000 | CA2337045A1 Cis acting nucleic acid elements and methods of use |
| 01/27/2000 | CA2336219A1 Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (kor-3) gene |
| 01/27/2000 | CA2336143A1 Aminoalkylphosphonic acid derivatives and their use in treating infections |
| 01/27/2000 | CA2335649A1 Gene sequence variances with utility in determining the treatment of disease |
| 01/27/2000 | CA2335274A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 01/27/2000 | CA2335101A1 Androgen receptor coactivators |
| 01/27/2000 | CA2335099A1 New caspase homologue |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/27/2000 | CA2334161A1 Use of nucleic acid molecules as antiviral agents |
| 01/27/2000 | CA2334080A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 01/27/2000 | CA2334075A1 Bone morphogenic protein |
| 01/27/2000 | CA2334045A1 Adenoviral based promoter assay |
| 01/27/2000 | CA2334039A1 Recombination repair gene, mim, from arabidopsis thaliana |
| 01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2333929A1 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | CA2333917A1 71 human secreted proteins |
| 01/27/2000 | CA2333912A1 Expression system containing chimeric promoters with binding sites for recombinant transcription factors |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333897A1 Process to collect metabolites from modified nectar by insects |
| 01/27/2000 | CA2333895A1 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof |
| 01/27/2000 | CA2333856A1 Serotype-specific probes for listeria monocytogenes |
| 01/27/2000 | CA2333853A1 Mucins |
| 01/27/2000 | CA2333471A1 Human scad-related molecules, scrm-1 and scrm-2 |
| 01/27/2000 | CA2333467A1 Human presenilin-associated protein |
| 01/27/2000 | CA2332722A1 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 01/27/2000 | CA2332634A1 Repression of cell transformation with human pea3 |
| 01/27/2000 | CA2331340A1 Glucoamylase variants |
| 01/27/2000 | CA2327921A1 Compositions and methods for fumonisin detoxification |
| 01/27/2000 | CA2303062A1 Human aspartic proteases |
| 01/26/2000 | EP0974668A1 Use of adenoviral E4 reading frames to improve expression of a gene of interest |
| 01/26/2000 | EP0974667A1 Process to collect metabolites from modified nectar by insects |
| 01/26/2000 | EP0974666A1 Methods for transferring gene into chromosome |
| 01/26/2000 | EP0974665A1 Recombinant yeast pdi and process for preparing the same |
| 01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
| 01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
| 01/26/2000 | EP0974662A1 Process for producing dihydroxyacetone 3-phosphate |
| 01/26/2000 | EP0974661A1 Geranyl diphosphate synthase genes |
| 01/26/2000 | EP0974660A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974658A1 PROBES FOR THE DIAGNOSIS OF INFECTIONS CAUSED BY $i(STREPTOCOCCUS PYOGENES) |
| 01/26/2000 | EP0974657A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 01/26/2000 | EP0974656A1 Dna gyrase inhibitor protein |
| 01/26/2000 | EP0974655A2 G-CSF analog compositions and methods |
| 01/26/2000 | EP0974654A2 Method for secretory production of human growth hormone |
| 01/26/2000 | EP0974653A2 Human gastric cancer antigen gene and protein |
| 01/26/2000 | EP0974652A1 Cancerous metastasis-associated gene |
| 01/26/2000 | EP0974651A1 Physiologically active protein originating in mammals |
| 01/26/2000 | EP0974650A1 Endothelial cell growth inhibitors |
| 01/26/2000 | EP0974649A1 Screening system |
| 01/26/2000 | EP0974647A1 Process for producing target substances by fermentation |
| 01/26/2000 | EP0974644A1 Method for producing freeze resitant yeast |
| 01/26/2000 | EP0974600A2 Anti-interleukin-18 antibody |
| 01/26/2000 | EP0974599A1 Recombinant single-stranded equine chorionic gonadotropin |
| 01/26/2000 | EP0974111A1 Apparatus and method for automated protein design |
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0974057A1 Methods to detect hk2 polypeptides |
| 01/26/2000 | EP0973948A2 Nucleic acid based detection of cytomegalovirus |
| 01/26/2000 | EP0973947A1 System for detecting nucleic acid hybridisation, preparation method and application thereof |
| 01/26/2000 | EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 01/26/2000 | EP0973943A1 Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| 01/26/2000 | EP0973940A1 AN $i(IN VITRO) METHOD FOR CONSTRUCTION OF A DNA LIBRARY |
| 01/26/2000 | EP0973939A1 Expression monitoring for gene function identification |
| 01/26/2000 | EP0973934A1 Transgenically produced non-secreted proteins |
| 01/26/2000 | EP0973931A1 Process for processing sucrose into glucose and fructose |
| 01/26/2000 | EP0973928A1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 01/26/2000 | EP0973927A1 Chimeric adenoviral coat protein and methods of using same |
| 01/26/2000 | EP0973926A1 Adenoviral vectors with modified tropism |
| 01/26/2000 | EP0973925A2 Matrix derived anti-hiv peptides and transdominant proteins |